As shown in Figure 2, the levels of CD62E, ICAM1, IL‐1 alpha, IL‐8, IP‐10, MCP‐1, and MIP‐1 beta were augmented in the COVID‐19 group while CD62P was greater in the non‐COVID‐19 group. This evidence concerns the gene CCL2 and COVID-19.